By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
OneBreath™ technology has the potential to accurately detect lung cancer earlier and more cost effectively than currently available screening methods.1
Lung cancer is the most deadly cancer in the United States
Lung cancer kills over 130,000 people annually, causing more deaths than colon, breast, and prostate cancer combined. Low screening compliance rates and limited accessibility of current screening methods highlights a glaring need for an alternative screening method to better serve the 14.5 million people at risk of developing lung cancer.
02 problem- Lung Cancer
Early diagnosis is the key to successful treatment of lung cancer.
OneBreath™ is designed to provide a safe, convenient, and affordable way to accurately identify lung cancer in at risk patients, before they know they have a problem.1
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
03 problem- Lung Cancer
OneBreath™: A Reliable, Accessible, and Cost-Effective Solution
OneBreath™ has the potential to transform the lung cancer screening landscape with the ability to detect early-stage lung cancer.1
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Our groundbreaking OneBreath™ technology is a cutting-edge breath analysis system designed to deliver an accurate, safe, and accessible lung cancer screening tool to patients and providers.1
OneBreath™ utilizes a patented chemical formulation and micro-reactor to capture and quantitatively count organic compounds contained in a single breath, with the ability to detect even early stage lung cancers.1
Breath Collection
Patients provide one complete breath via a unique collection system in less than 30 seconds.
Breath Analysis & Processing
In a simple automated process, the OneBreath™ micro-reactor captures a spectrum of organic compounds contained in the breath. Once captured, the sample is analyzed in our laboratory.
Get Results
Results will be available to physicians and patients within 3-4 business days.
Dr. Victor van Berkel, MD, PhD is a Professor of Surgery in the Department of Cardiovascular and Thoracic Surgery at the University of Louisville, as well as Chief of the Division of Thoracic Surgery and is currently the vice-chair of the Department. He is a co-investigator for several oncologic clinical trials through the Brown Cancer Center, and sits on two FDA panels that deal with the approval of medical devices. In addition to his clinical practice, he has an active research lab - his research on the use of breath analysis to identify lung cancer led to him being a cofounder of Breath Diagnostics, Inc.
Michael Bousamara
Founder and Director
Dr Bousamra is the Head of Thoracic Surgery for Ascension Health SE Michigan and a member of the American Association for Thoracic Surgery. He has authored over 50 peer-reviewed publications and holds several patents on methods to detect cancer.
Phil Douglas
Chairman and Director
Phillip B. Douglas has 40 years of experience as a seasoned and innovative leader who has management and board experience which spans diverse organizational settings and industries. In addition to serving as a Director of Breath Diagnostics, Mr. Douglas currently serves on the Board of Directors of Oceans Healthcare, PartnerCare, Ernest Healthcare, The Ear Nose Throat & Plastic Surgery Associates (“ENTPSA”), Palmetto Technology Group (“PTG”) and Volta Inc. Previously Phil was the Executive Chairman of KureSmart Pain Management and Chairman and CEO of LifeCare Health Partners, which operated 25 locations in 9 states and experienced significant revenue and earnings growth under Mr. Douglas’ leadership. Mr. Douglas previously held senior executive positions with Humana and United Healthcare. Mr. Douglas is a graduate of the University of Kentucky and was a CPA with Price Waterhouse Coopers.
Jeff Rich
Director
Dr. Rich is currently the Cleveland Clinic’s Chairman of Operations and Strategy for the Sydell and Arnold Miller Family Heart & Vascular Institute. He previously served as the Surgical Director of the Sentara Cardiac Research Institute, as past President of the Society of Thoracic Surgeons and held leadership positions within the National Quality Forum (NQF). In addition, Dr. Rich served as the Director of the Center for Medicare at the Centers for Medicare and Medicaid Services (CMS). He testified four times before Congress and has served on Federal Advisory Committees for CMS as well as the FDA Circulatory System Devices Panel of the Medical Devices Advisory Committee.
Ivan Lo
CEO and Director
Ivan Lo is the founder of Wealth Stream Capital Corp, a family office that invests in private and public companies across various sectors. WSCC was formed as a result of the seed and early-stage investments Ivan Lo has made, which have led to multiple exits and companies that have surpassed unicorn valuations. Ivan has led multiple strategic financing initiatives, and has been instrumental in the success of numerous private and public companies, playing a key role in the structure and financing of companies across various sectors. He has funded over 100 private and public companies who collectively have raised over $1 billion.
OneBreath™ by Breath Diagnostics
OneBreath™ may save your life.
Contact us to discover the future of lung cancer screening or click below to learn more.1